Obesity rates are stabilizing in rich countries but increasing in developing countries.
19 May 2026
The IIS Aragón receives the Aragonese of the Year award in the Science and Technology category
21 May 2026
The Aragon Health Research Institute (IIS Aragon), through its Clinical Research Unit, manages the clinical trials carried out in all hospitals and primary care centers in Aragon.
Nearly half of the patients participate in oncology studies, the most active discipline in the region. This clinical research is conducted before a new drug is marketed and is carried out with the highest safety standards for patients.
Today, Wednesday, May 20th, is the celebration of World Clinical Trials DayThis event underscores the importance of clinical research for advancing medicine and innovative therapies. Aragon currently has 523 active clinical trials, of which 189 are developed in oncology, concentrating approximately 36% of the totalFurthermore, other services such as gastroenterology, neurology, hematology, infectious diseases, ophthalmology, and dermatology have a significant number of studies, reflecting the diversity and scope of research in the region. Moreover, patient participation exceeds 2.062and nearly half of them are involved in cancer studies.
Clinical trials are research studies These studies allow for the evaluation of new medications, treatments, medical devices, or methods of prevention and diagnosis before they can be incorporated into routine practice. Thanks to them, it is possible to verify whether these advances are effective and safe, always under strict medical and ethical controls. “The clinical research we conduct in Aragon is carried out with the maximum security guarantees “This is important for patients and is essential for evaluating the effectiveness of new treatments, medical devices, or therapies. The Clinical Research Unit of the IIS Aragón coordinates these studies in all hospitals and primary care centers, ensuring that each trial contributes to the advancement of medicine,” he explains. Eva López, coordinator of the Clinical Research Unit of the IIS Aragón.
Participation in a clinical trial is always voluntary. and may offer some patients access to innovative treatments before it is marketed. Each study establishes specific participation criteria based on the disease, age, or clinical condition of the candidates. In addition, all participants receive detailed information before deciding whether they wish to participate in the study and They can leave the trial at any time.
The distribution by centers shows that More than 90% of clinical trials are conducted at the Miguel Servet University Hospital and the Lozano Blesa University Clinical HospitalPrimary care centers are participating with 19 active studies, integrating the entire Aragonese health network into clinical research.
All clinical trials have the favorable opinion of a Research Ethics Committee for Medicines (CEIm) and with the authorization of the European Medicines Agency (EMA)Patient information is handled confidentially, in strict compliance with European and national data protection regulations.
“The results of clinical trials allow us to make informed decisions about the usefulness of treatments, support the authorization of new medicines, and continue to offer increasingly safe and effective therapies,” he says. Eva Lopez. Furthermore, the Coordinator of the Clinical Research Unit of the IIS Aragón It adds that "patients can access information about the studies they are participating in and all personnel involved in the trials are required to protect the confidentiality of their data in accordance with current regulations."
With these initiatives, Aragon reaffirms its leadership in clinical research, promoting innovative, safe and effective treatments that contribute to improving the health and quality of life of patients.
